Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - GENVEC INC | v242943_ex99-1.htm |
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 7, 2011
GENVEC, INC.
(Exact name of registrant as specified in its charter)
|
Delaware
|
0-24469
|
23-2705690
|
|
(State or other jurisdiction
|
(Commission
|
(IRS Employer
|
|
of Incorporation)
|
File Number)
|
Identification No.)
|
|
65 West Watkins Mill Road, Gaithersburg, Maryland
|
20878
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Registrant’s telephone number, including area code:
|
(240) 632 0740
|
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
|
INFORMATION TO BE INCLUDED IN THE REPORT
Section 5 – Corporate Governance and Management
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 7, 2011, Paul H. Fischer, Ph.D., the President and Chief Executive Officer of GenVec, Inc. (“GenVec”), informed the Board of Directors (the “Board”) of his plan to retire as President and Chief Executive Officer. Dr. Fischer will continue to serve GenVec in his current role until a successor is named by the Board.
Consistent with its succession planning, the Board has retained Spencer Stuart, an executive recruiting firm, to assist in the search for a successor to Dr. Fischer.
On December 13, 2011, GenVec issued a press release regarding Dr. Fischer’s planned retirement. A copy of the press release is attached as Exhibit 99.1 to this Current Report.
Section 9 – Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
|
(d)
|
Exhibits
|
|
99.1
|
GenVec, Inc. press release dated December 13, 2011, announcing planned retirement of Paul H. Fischer, Ph.D., President and Chief Executive Officer.
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
GENVEC, INC.
|
||
|
Date: December 13, 2011
|
By:
|
/s/
DOUGLAS J. SWIRSKY
|
|
Douglas J. Swirsky
|
||
| Senior Vice President, Chief Financial Officer, Treasurer and Corporate Secretary | ||
3
EXHIBIT INDEX
|
99.1
|
GenVec, Inc. press release dated December 13, 2011, announcing planned retirement of Paul H. Fischer, Ph.D., President and Chief Executive Officer.
|
4